NCT07731633

Brief Summary

At baseline, venous blood samples were collected from all eligible participants. The following biochemical parameters were analysed: serum electrolytes (mineral profile), fasting glucose, creatinine, urea nitrogen, total proteins, albumin, bilirubin, liver enzymes, C-reactive protein (CRP), total cholesterol, triacylglycerols (TAG), serum iron, active vitamin D, vitamin B12, complete blood count. At baseline, all participants also underwent standardized anthropometric measurements, including height (cm), body weight (kg) and BMI was calculated accordingly. Body composition was assessed using bioelectrical impedance analysis with the InBody Tanita MC-780MA device. The following parameters were recorded: total body fat (kg, %), visceral fat (kg, %), skeletal muscle mass (kg, %), total muscle mass (kg, %), total body water (kg, %), sarcopenic index (kg/m²), phase angle. To assess health-related quality of life and symptom burden, all participants completed validated questionnaires: World Health Organization Quality of Life - Brief Version (WHOQOL-BREF), Patient Assessment of Gastrointestinal Disorders - Symptom Severity Index (PAGI-SYM), Patient-Reported Outcomes Measurement Information System Global Health-10 (PROMIS-10), Patient Assessment of Upper Gastrointestinal Disorders - Quality of Life (PAGI-QoL) and Patient Health Questionnaire-15 (PHQ-15). After the one-month intervention, participants in the VEG group repeated laboratory testing, anthropometric assessment, body composition analysis, and questionnaire evaluation. The same follow-up assessments were performed in the WD group for comparative purposes. Long-term vegans (VEG-P) did not undergo repeated measurements. Dietary Monitoring and Adherence At study enrolment, all participants were offered a dietary consultation to improve adherence to the assigned dietary regimen. Participants were also instructed to maintain a food diary throughout the study period, which was periodically reviewed via telephone or email consultation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 16, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 5, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 5, 2024

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

July 15, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

July 28, 2026

Completed
Last Updated

July 28, 2026

Status Verified

July 1, 2026

Enrollment Period

1.3 years

First QC Date

July 15, 2026

Last Update Submit

July 25, 2026

Conditions

Keywords

vegan dietdietary interventionbody compositionmetabolic adaptationquality of life

Outcome Measures

Primary Outcomes (6)

  • The difference in body weight (kg), between healthy vegans (more than 2 years) and omnivores.

    To comprehensively compare body weight among individuals following different dietary patterns (long-term vegans and omnivores).

    Baseline

  • The difference in body weight (kg) between omnivores and intervention group (omnivores transitioned to vegan diet).

    To comprehensively compare body weight among individuals following different dietary patterns (long-term omnivores and intervention group).

    From baseline to the end of intervention at 4 weeks

  • The difference in lipid profile (total cholesterol, triglycerides), between healthy vegans (more than 2 years) and omnivores.

    At baseline, venous blood samples were collected from all eligible participants to analyse lipid profile: total cholesterol (mmol/l), triaglycerides (mmol/l).

    Baseline

  • The difference in C-reactive protein (CRP), between healthy vegans (more than 2 years) and omnivores.

    At baseline, venous blood samples were collected from all eligible participants to analyse CRP (mg/l).

    Baseline

  • The difference in lipid profile (total cholesterol, triglycerides) between omnivores and intervention group (omnivores transitioned to vegan diet).

    To comprehensively compare lipid profile parameters among individuals following different dietary patterns (long-term omnivores and intervention group). Venous blood samples were analyzed to measure total cholesterol (mmol/l) and triglycerides (mmol/l).

    From baseline to the end of intervention at 4 weeks

  • The difference in C-reactive protein (CRP) between omnivores and intervention group (omnivores transitioned to vegan diet).

    To comprehensively compare CRP parameters among individuals following different dietary patterns (long-term omnivores and intervention group). Venous blood samples were analyzed to measure CRP (mg/l).

    From baseline to the end of intervention at 4 weeks.

Secondary Outcomes (5)

  • World Health Organization Quality of Life - Brief Version (WHOQOL-BREF)

    From baseline to the end of intervention at 4 weeks

  • Patient Assessment of Gastrointestinal Disorders - Symptom Severity Index (PAGI-SYM).

    From baseline to the end of intervention at 4 weeks.

  • Patient-Reported Outcomes Measurement Information System Global Health-10 (PROMIS-10).

    From baseline to the end of intervention at 4 weeks.

  • Patient Assessment of Upper Gastrointestinal Disorders - Quality of Life (PAGI-QoL).

    From baseline to the end of intervention at 4 weeks.

  • Patient Health Questionnaire-15 (PHQ-15).

    From baseline to the end of intervention at 4 weeks.

Study Arms (1)

VEG

EXPERIMENTAL

omnivores transmitted to vegan diet

Dietary Supplement: vegan diet

Interventions

vegan dietDIETARY_SUPPLEMENT

omnivores transmitted to vegan diet

VEG

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years
  • Healthy individuals without chronic disease
  • BMI between 18 and 30 kg/m²
  • Provision of written informed consent
  • For the VEG-P group: exclusive adherence to a plant-based diet for at least 2 years
  • For the WD group: regular consumption of animal products for at least 2 years

You may not qualify if:

  • Active infection
  • Eating disorder
  • Severe or unstable metabolic disease (e.g., diabetes mellitus)
  • Endocrine disorders
  • BMI \< 18 or \> 30 kg/m²
  • Age \< 18 years
  • Current or past malignancy
  • Systemic corticosteroid therapy
  • Hormone replacement therapy
  • Pregnancy
  • Inability to complete follow-up assessments
  • Excessive alcohol consumption

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Martin

Martin, Žilina Region, 03601, Slovakia

Location

MeSH Terms

Interventions

Diet, Vegan

Intervention Hierarchy (Ancestors)

Diet, VegetarianDiet, Plant-BasedDiet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Investigator

Study Record Dates

First Submitted

July 15, 2026

First Posted

July 28, 2026

Study Start

February 16, 2023

Primary Completion

June 5, 2024

Study Completion

June 5, 2024

Last Updated

July 28, 2026

Record last verified: 2026-07

Locations